Bavarian Nordic A/S (BVNKF)
OTCMKTS
· Delayed Price · Currency is USD
24.23
0.00 (0.00%)
Mar 12, 2025, 4:00 PM EST
Bavarian Nordic Employees
Bavarian Nordic had 1,605 employees as of December 31, 2024. The number of employees increased by 226 or 16.39% compared to the previous year.
Employees
1,605
Change (1Y)
226
Growth (1Y)
16.39%
Revenue / Employee
$494,415
Profits / Employee
$85,454
Market Cap
1.85B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Bavarian Nordic News
- 2 days ago - Bavarian Nordic A/S – Notice Convening Annual General Meeting - GlobeNewsWire
- 7 days ago - Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older - GlobeNewsWire
- 8 days ago - Bavarian Nordic A/S (BVNKF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 9 days ago - Bavarian Nordic Publishes Annual Report 2024 - GlobeNewsWire
- 14 days ago - Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older - GlobeNewsWire
- 16 days ago - Biological E in strategic pact with Danish co Bavarian Nordic to manufacture Chikungunya vax for global access - The Times of India
- 17 days ago - Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine - GlobeNewsWire